The FDA warned consumers and health care providers today regarding a serious recall initiated by Staska Pharmaceuticals, Inc. of one lot of their Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials. The company issued the recall last Thursday after discovering potential contamination with glass particulate.
The recalled Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL 50mL is an injectable form of vitamin C that is available by prescription only. The lot or batch number on the recalled product is SP2400058, and the “best used by date” (BUD) is 12/31/2024. The product comes packaged in amber-colored vials in a white box. The batch and BUD numbers are printed on the front of the box along with the date of manufacture. Staska Pharmaceuticals distributed the product throughout the United States from 07/31/2024 to 08/27/2024.
While no injuries have been reported thus far in connection to the recalled product, Staska Pharmaceuticals asks health care professionals to refrain from administering the affected batch. Injection of particulate can cause symptoms in patients that range in severity from swelling or inflammation at the site of injection to pulmonary, cardiac, or cerebral embolism. In some cases, the latter could lead to stroke or even death.
The company asks that all customers and health care providers stop using the recalled product immediately. Health care facilities are asked to quarantine the product. Staska Pharmaceuticals has contacted customers directly with instructions for returning the recalled product in exchange for a replacement. Those who have not received notification from Staska directly can reach out to the company to discuss a replacement.
Staska Pharmaceuticals is available for questions Monday through Friday from 8 a.m. to 5 p.m. CST at 402-782-2207 or 888-801-1370.
If you or a loved one has suffered an injury or adverse health outcome after receiving a pharmaceutical injection contaminated with glass particulate, we urge you to get in touch with our team. It’s vital that the liable parties be held accountable for their negligence to prevent the further distribution of dangerous medication to health care facilities in the United States. Our experienced attorneys at TruLaw are prepared to learn about your story and help you begin building a case for just compensation. Contact us today or try out our free Instant Case Evaluation ℠ to get started.